TG Therapeutics, Inc. (TGTX)

TG Therapeutics Stock Forecast

Stock Price Forecast

The 5 analysts with 12-month price forecasts for TG Therapeutics stock have an average target of 31.2, with a low estimate of 13 and a high estimate of 49. The average target predicts an increase of 48.57% from the current stock price of 21.00.

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$13	$31.2	$29	$49
Change	-38.10%	+48.57%	+38.10%	+133.33%

* Price targets were last updated on May 2, 2024.

Analyst Ratings

The average analyst rating for TGTX stock from 6 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Feb '24	Mar '24	Apr '24	May '24	Jun '24	Jul '24
Strong Buy	4	4	4	4	4	4
Buy	2	2	1	1	1	1
Hold	1	1	1	1	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	7	7	6	6	6	6

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Edward White HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Maintains $45 → $49	Strong Buy	Maintains	$45 → $49	+133.33%	May 2, 2024
Matthew Kaplan Ladenburg Thalmann	Ladenburg Thalmann	Strong Buy Maintains $39 → $40	Strong Buy	Maintains	$39 → $40	+90.48%	May 2, 2024
Edward White HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $45	Strong Buy	Reiterates	$45	+114.29%	Apr 18, 2024
Eric Joseph JP Morgan	JP Morgan	Buy Reiterates $25	Buy	Reiterates	$25	+19.05%	Apr 18, 2024
Matthew Kaplan Ladenburg Thalmann	Ladenburg Thalmann	Strong Buy Reiterates $39	Strong Buy	Reiterates	$39	+85.71%	Apr 18, 2024

More Analyst Ratings

Financial Forecast

Revenue This Year

314.90M

Increased by 34.77%

from 233.66M

Revenue Next Year

481.82M

Increased by 53.01%

from 314.90M

EPS This Year

-0.02

from 0.09

EPS Next Year

0.60

from -0.02

Year	2019	2020	2021	2022	2023	2024	2025	2026	2027	2028
Revenue	152.00K	152.00K	6.69M	2.79M	233.66M	314.90M	481.82M	699.34M	1.04B	1.32B
Revenue Growth	-	-	4,300.66%	-58.36%	8,290.02%	34.77%	53.01%	45.15%	48.85%	26.80%
EPS	-1.96	-2.42	-2.63	-1.46	0.09	-0.02	0.60	1.41	2.59	3.91
EPS Growth	-	-	-	-	-	-	-	136.25%	83.03%	51.28%
Forward PE	-	-	-	-	-	-	35.12	14.87	8.12	5.37
No. Analysts	-	-	-	-	-	10	10	8	4	4

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2024	2025	2026	2027	2028
High	411.1M	554.4M	1.1B	1.1B	1.4B
Avg	314.9M	481.8M	699.3M	1.0B	1.3B
Low	285.4M	357.1M	437.2M	993.7M	1.2B

Revenue Growth

Revenue Growth	2024	2025	2026	2027	2028
High	75.9%	76.1%	124.6%	54.3%	35.1%
Avg	34.8%	53.0%	45.1%	48.9%	26.8%
Low	22.1%	13.4%	-9.3%	42.1%	17.6%

EPS Forecast

EPS	2024	2025	2026	2027	2028
High	0.47	1.07	3.31	2.67	4.42
Avg	-0.02	0.60	1.41	2.59	3.91
Low	-0.25	0.11	0.45	2.48	3.39

EPS Growth

EPS Growth	2024	2025	2026	2027	2028
High	425.0%	-	453.1%	88.8%	71.0%
Avg	-	-	136.2%	83.0%	51.3%
Low	-	-	-24.6%	75.5%	31.1%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.